Raymond James Financial Services Advisors Inc. lifted its position in Viewray Inc (NASDAQ:VRAY) by 4.3% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 74,440 shares of the company’s stock after buying an additional 3,090 shares during the quarter. Raymond James Financial Services Advisors Inc.’s holdings in Viewray were worth $550,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Candriam Luxembourg S.C.A. grew its stake in shares of Viewray by 1,204.8% in the 1st quarter. Candriam Luxembourg S.C.A. now owns 132,857 shares of the company’s stock valued at $982,000 after buying an additional 122,675 shares in the last quarter. Northern Trust Corp grew its stake in shares of Viewray by 2.7% in the 4th quarter. Northern Trust Corp now owns 836,280 shares of the company’s stock valued at $5,077,000 after buying an additional 22,187 shares in the last quarter. Essex Investment Management Co. LLC grew its stake in shares of Viewray by 2.9% in the 4th quarter. Essex Investment Management Co. LLC now owns 245,232 shares of the company’s stock valued at $1,489,000 after buying an additional 6,897 shares in the last quarter. Prescott Group Capital Management L.L.C. grew its stake in shares of Viewray by 1,141.9% in the 4th quarter. Prescott Group Capital Management L.L.C. now owns 200,476 shares of the company’s stock valued at $1,217,000 after buying an additional 184,333 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its stake in shares of Viewray by 73.6% in the 3rd quarter. Bank of New York Mellon Corp now owns 283,017 shares of the company’s stock valued at $2,650,000 after buying an additional 120,016 shares in the last quarter.

Several equities research analysts recently commented on the company. BidaskClub cut Viewray from a “hold” rating to a “sell” rating in a research note on Monday. Zacks Investment Research cut Viewray from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 20th. TheStreet raised Viewray from a “d+” rating to a “c-” rating in a research report on Thursday, March 21st. ValuEngine raised Viewray from a “buy” rating to a “strong-buy” rating in a research report on Monday, May 13th. Finally, B. Riley reaffirmed a “buy” rating and set a $12.00 target price (down previously from $13.75) on shares of Viewray in a research report on Monday, March 11th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. Viewray has a consensus rating of “Buy” and an average price target of $12.63.

Shares of Viewray stock opened at $8.87 on Friday. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.28 and a quick ratio of 3.21. Viewray Inc has a 12-month low of $4.86 and a 12-month high of $13.21.

Viewray (NASDAQ:VRAY) last announced its earnings results on Thursday, May 2nd. The company reported ($0.34) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.12). The company had revenue of $20.30 million for the quarter, compared to the consensus estimate of $20.40 million. Viewray had a negative return on equity of 71.16% and a negative net margin of 139.82%. The firm’s revenue for the quarter was down 22.5% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.11) EPS. Equities analysts expect that Viewray Inc will post -1.02 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This piece of content was published by Watch List News and is the property of of Watch List News. If you are reading this piece of content on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark laws. The legal version of this piece of content can be accessed at https://www.watchlistnews.com/raymond-james-financial-services-advisors-inc-purchases-3090-shares-of-viewray-inc-nasdaqvray/3041356.html.

About Viewray

ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.

Read More: Elliott Wave Theory

Want to see what other hedge funds are holding VRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Viewray Inc (NASDAQ:VRAY).

Institutional Ownership by Quarter for Viewray (NASDAQ:VRAY)

Receive News & Ratings for Viewray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viewray and related companies with MarketBeat.com's FREE daily email newsletter.